APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gout Medications

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gout Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025190 pages

Choose your research edition.

Industry ResearchGout Medications Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Gout Medications Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Gout Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gout Medications Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Gout Medications Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Gout Medications market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Gout Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gout Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gout Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gout Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gout Medications include AstraZeneca, FUJI YAKUHIN, Hikma Pharmaceuticals plc, lroko Pharmaceuticals, Merck, Novartis, Sanofi, Savient Pharmaceuticals, Inc. and Sebelalreland, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gout Medications market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gout Medications and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gout Medications sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gout Medications market size, projected growth trends, production technologies, key applications, and end-use industries.

Gout Medications Segment by Company

AstraZeneca

FUJI YAKUHIN

Hikma Pharmaceuticals plc

lroko Pharmaceuticals

Merck

Novartis

Sanofi

Savient Pharmaceuticals, Inc.

Sebelalreland

Takeda Pharmaceutical Company Limited

Teijin Pharma

Astellas Pharma Hong Kong Co., Ltd

Haichuang Pharmaceutical

Hengrui Medicine

Tonghua Dongbao

ApicHope

INVENTISBIO CO. LTD.

Gout Medications Segment by Type

Gout Relief Drugs

Gout Treatment Drugs

Gout Medications Segment by Application

Primary Gout

Secondary Gout

Gout Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gout Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gout Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gout Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gout Medications market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gout Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Gout Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Gout Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Gout Medications Industry Trends Table 2. Gout Medications Industry Drivers Table 3. Gout Medications Industry Opportunities and Challenges Table 4. Gout Medications Industry Restraints Table 5. Global Gout Medications Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Gout Medications Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Gout Medications Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Gout Medications Sales Market Share by Manufacturers Table 9. Global Gout Medications Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Gout Medications Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Gout Medications Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Gout Medications Manufacturers, Product Type & Application Table 13. Global Gout Medications Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Gout Medications by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Gout Relief Drugs Table 17. Major Manufacturers of Gout Treatment Drugs Table 18. Global Gout Medications Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Gout Medications Sales by Type (2021-2026) & (K Units) Table 20. Global Gout Medications Sales by Type (2027-2032) & (K Units) Table 21. Global Gout Medications Sales Market Share by Type (2021-2026) Table 22. Global Gout Medications Sales Market Share by Type (2027-2032) Table 23. Global Gout Medications Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Gout Medications Revenue by Type (2021-2026) & (K Units) Table 25. Global Gout Medications Revenue by Type (2027-2032) & (K Units) Table 26. Global Gout Medications Revenue Market Share by Type (2021-2026) Table 27. Global Gout Medications Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Primary Gout Table 29. Major Manufacturers of Secondary Gout Table 30. Global Gout Medications Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Gout Medications Sales by Application (2021-2026) & (K Units) Table 32. Global Gout Medications Sales by Application (2027-2032) & (K Units) Table 33. Global Gout Medications Sales Market Share by Application (2021-2026) Table 34. Global Gout Medications Sales Market Share by Application (2027-2032) Table 35. Global Gout Medications Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Gout Medications Revenue by Application (2021-2026) & (K Units) Table 37. Global Gout Medications Revenue by Application (2027-2032) & (K Units) Table 38. Global Gout Medications Revenue Market Share by Application (2021-2026) Table 39. Global Gout Medications Revenue Market Share by Application (2027-2032) Table 40. Global Gout Medications Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Gout Medications Sales by Region (2021-2026) & (K Units) Table 42. Global Gout Medications Sales Market Share by Region (2021-2026) Table 43. Global Gout Medications Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Gout Medications Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Gout Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Gout Medications Sales by Country (2021-2026) & (K Units) Table 47. North America Gout Medications Sales by Country (2027-2032) & (K Units) Table 48. Europe Gout Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Gout Medications Sales by Country (2021-2026) & (K Units) Table 50. Europe Gout Medications Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Gout Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Gout Medications Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Gout Medications Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Gout Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Gout Medications Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Gout Medications Sales by Country (2027-2032) & (K Units) Table 57. Global Gout Medications Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Gout Medications Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Gout Medications Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Gout Medications Revenue Market Share by Region (2021-2026) Table 61. Global Gout Medications Revenue Market Share by Region (2027-2032) Table 62. AstraZeneca Company Information Table 63. AstraZeneca Business Overview Table 64. AstraZeneca Gout Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. AstraZeneca Gout Medications Product Portfolio Table 66. AstraZeneca Recent Development Table 67. FUJI YAKUHIN Company Information Table 68. FUJI YAKUHIN Business Overview Table 69. FUJI YAKUHIN Gout Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. FUJI YAKUHIN Gout Medications Product Portfolio Table 71. FUJI YAKUHIN Recent Development Table 72. Hikma Pharmaceuticals plc Company Information Table 73. Hikma Pharmaceuticals plc Business Overview Table 74. Hikma Pharmaceuticals plc Gout Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Hikma Pharmaceuticals plc Gout Medications Product Portfolio Table 76. Hikma Pharmaceuticals plc Recent Development Table 77. lroko Pharmaceuticals Company Information Table 78. lroko Pharmaceuticals Business Overview Table 79. lroko Pharmaceuticals Gout Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. lroko Pharmaceuticals Gout Medications Product Portfolio Table 81. lroko Pharmaceuticals Recent Development Table 82. Merck Company Information Table 83. Merck Business Overview Table 84. Merck Gout Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Merck Gout Medications Product Portfolio Table 86. Merck Recent Development Table 87. Novartis Company Information Table 88. Novartis Business Overview Table 89. Novartis Gout Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Novartis Gout Medications Product Portfolio Table 91. Novartis Recent Development Table 92. Sanofi Company Information Table 93. Sanofi Business Overview Table 94. Sanofi Gout Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Sanofi Gout Medications Product Portfolio Table 96. Sanofi Recent Development Table 97. Savient Pharmaceuticals, Inc. Company Information Table 98. Savient Pharmaceuticals, Inc. Business Overview Table 99. Savient Pharmaceuticals, Inc. Gout Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Savient Pharmaceuticals, Inc. Gout Medications Product Portfolio Table 101. Savient Pharmaceuticals, Inc. Recent Development Table 102. Sebelalreland Company Information Table 103. Sebelalreland Business Overview Table 104. Sebelalreland Gout Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Sebelalreland Gout Medications Product Portfolio Table 106. Sebelalreland Recent Development Table 107. Takeda Pharmaceutical Company Limited Company Information Table 108. Takeda Pharmaceutical Company Limited Business Overview Table 109. Takeda Pharmaceutical Company Limited Gout Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Takeda Pharmaceutical Company Limited Gout Medications Product Portfolio Table 111. Takeda Pharmaceutical Company Limited Recent Development Table 112. Teijin Pharma Company Information Table 113. Teijin Pharma Business Overview Table 114. Teijin Pharma Gout Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Teijin Pharma Gout Medications Product Portfolio Table 116. Teijin Pharma Recent Development Table 117. Astellas Pharma Hong Kong Co., Ltd Company Information Table 118. Astellas Pharma Hong Kong Co., Ltd Business Overview Table 119. Astellas Pharma Hong Kong Co., Ltd Gout Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Astellas Pharma Hong Kong Co., Ltd Gout Medications Product Portfolio Table 121. Astellas Pharma Hong Kong Co., Ltd Recent Development Table 122. Haichuang Pharmaceutical Company Information Table 123. Haichuang Pharmaceutical Business Overview Table 124. Haichuang Pharmaceutical Gout Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Haichuang Pharmaceutical Gout Medications Product Portfolio Table 126. Haichuang Pharmaceutical Recent Development Table 127. Hengrui Medicine Company Information Table 128. Hengrui Medicine Business Overview Table 129. Hengrui Medicine Gout Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Hengrui Medicine Gout Medications Product Portfolio Table 131. Hengrui Medicine Recent Development Table 132. Tonghua Dongbao Company Information Table 133. Tonghua Dongbao Business Overview Table 134. Tonghua Dongbao Gout Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Tonghua Dongbao Gout Medications Product Portfolio Table 136. Tonghua Dongbao Recent Development Table 137. ApicHope Company Information Table 138. ApicHope Business Overview Table 139. ApicHope Gout Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. ApicHope Gout Medications Product Portfolio Table 141. ApicHope Recent Development Table 142. INVENTISBIO CO. LTD. Company Information Table 143. INVENTISBIO CO. LTD. Business Overview Table 144. INVENTISBIO CO. LTD. Gout Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. INVENTISBIO CO. LTD. Gout Medications Product Portfolio Table 146. INVENTISBIO CO. LTD. Recent Development Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Gout Medications Distributors List Table 150. Gout Medications Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Gout Medications Product Image Figure 2. Global Gout Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gout Medications Market Size (2021-2032) & (US$ Million) Figure 4. Global Gout Medications Sales (2021-2032) & (K Units) Figure 5. Global Gout Medications Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Gout Medications Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Gout Relief Drugs Image Figure 9. Gout Treatment Drugs Image Figure 10. Global Gout Medications Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Gout Medications Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Gout Medications Sales Market Share by Type (2021-2032) Figure 13. Global Gout Medications Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Gout Medications Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Gout Medications Revenue Market Share by Type (2021-2032) Figure 16. Primary Gout Image Figure 17. Secondary Gout Image Figure 18. Global Gout Medications Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Gout Medications Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Gout Medications Sales Market Share by Application (2021-2032) Figure 21. Global Gout Medications Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Gout Medications Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Gout Medications Revenue Market Share by Application (2021-2032) Figure 24. North America Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Gout Medications Sales Market Share by Country (2021-2032) Figure 26. U.S. Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Gout Medications Sales Market Share by Country (2021-2032) Figure 31. Germany Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Gout Medications Sales Market Share by Country (2021-2032) Figure 38. China Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Gout Medications Sales Market Share by Country (2021-2032) Figure 46. Brazil Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Gout Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Gout Medications Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Gout Medications Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Gout Medications Revenue (2021-2032) & (US$ Million) Figure 57. North America Gout Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Gout Medications Revenue (2021-2032) & (US$ Million) Figure 59. Europe Gout Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Gout Medications Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Gout Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Gout Medications Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Gout Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Gout Medications Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Gout Medications Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Gout Relief Drugs
  • Gout Treatment Drugs
Applications
  • Primary Gout
  • Secondary Gout
Companies covered
  • AstraZeneca
  • FUJI YAKUHIN
  • Hikma Pharmaceuticals plc
  • lroko Pharmaceuticals
  • Merck
  • Novartis
  • Sanofi
  • Savient Pharmaceuticals, Inc.
  • Sebelalreland
  • Takeda Pharmaceutical Company Limited
  • Teijin Pharma
  • Astellas Pharma Hong Kong Co., Ltd
  • Haichuang Pharmaceutical
  • Hengrui Medicine
  • Tonghua Dongbao
  • ApicHope
  • INVENTISBIO CO. LTD.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gout Medications Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gout Medications Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Gout Medications Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Gout Medications Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Gout Medications Market Dynamics
  1. 2.1 Gout Medications Industry Trends
  2. 2.2 Gout Medications Industry Drivers
  3. 2.3 Gout Medications Industry Opportunities and Challenges
  4. 2.4 Gout Medications Industry Restraints
3 Gout Medications Market by Manufacturers
  1. 3.1 Global Gout Medications Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Gout Medications Sales by Manufacturers (2021-2026)
  3. 3.3 Global Gout Medications Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Gout Medications Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gout Medications Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Gout Medications Manufacturers, Product Type & Application
  7. 3.7 Global Gout Medications Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gout Medications Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gout Medications Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gout Medications Tier 1, Tier 2, and Tier 3
4 Gout Medications Market by Type
  1. 4.1 Gout Medications Type Introduction
  2. 4.1.1 Gout Relief Drugs
  3. 4.1.2 Gout Treatment Drugs
  4. 4.2 Global Gout Medications Sales by Type
  5. 4.2.1 Global Gout Medications Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Gout Medications Sales by Type (2021-2032)
  7. 4.2.3 Global Gout Medications Sales Market Share by Type (2021-2032)
  8. 4.3 Global Gout Medications Revenue by Type
  9. 4.3.1 Global Gout Medications Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Gout Medications Revenue by Type (2021-2032)
  11. 4.3.3 Global Gout Medications Revenue Market Share by Type (2021-2032)
5 Gout Medications Market by Application
  1. 5.1 Gout Medications Application Introduction
  2. 5.1.1 Primary Gout
  3. 5.1.2 Secondary Gout
  4. 5.2 Global Gout Medications Sales by Application
  5. 5.2.1 Global Gout Medications Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Gout Medications Sales by Application (2021-2032)
  7. 5.2.3 Global Gout Medications Sales Market Share by Application (2021-2032)
  8. 5.3 Global Gout Medications Revenue by Application
  9. 5.3.1 Global Gout Medications Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Gout Medications Revenue by Application (2021-2032)
  11. 5.3.3 Global Gout Medications Revenue Market Share by Application (2021-2032)
6 Global Gout Medications Sales by Region
  1. 6.1 Global Gout Medications Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gout Medications Sales by Region (2021-2032)
  3. 6.2.1 Global Gout Medications Sales by Region (2021-2026)
  4. 6.2.2 Global Gout Medications Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gout Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Gout Medications Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Gout Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Gout Medications Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Gout Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Gout Medications Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Gout Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Gout Medications Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Gout Medications Revenue by Region
  1. 7.1 Global Gout Medications Revenue by Region
  2. 7.1.1 Global Gout Medications Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Gout Medications Revenue by Region (2021-2026)
  4. 7.1.3 Global Gout Medications Revenue by Region (2027-2032)
  5. 7.1.4 Global Gout Medications Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Gout Medications Revenue (2021-2032)
  8. 7.2.2 North America Gout Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Gout Medications Revenue (2021-2032)
  11. 7.3.2 Europe Gout Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Gout Medications Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Gout Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Gout Medications Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Gout Medications Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AstraZeneca
  2. 8.1.1 AstraZeneca Company Information
  3. 8.1.2 AstraZeneca Business Overview
  4. 8.1.3 AstraZeneca Gout Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AstraZeneca Gout Medications Product Portfolio
  6. 8.1.5 AstraZeneca Recent Developments
  7. 8.2 FUJI YAKUHIN
  8. 8.2.1 FUJI YAKUHIN Company Information
  9. 8.2.2 FUJI YAKUHIN Business Overview
  10. 8.2.3 FUJI YAKUHIN Gout Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 FUJI YAKUHIN Gout Medications Product Portfolio
  12. 8.2.5 FUJI YAKUHIN Recent Developments
  13. 8.3 Hikma Pharmaceuticals plc
  14. 8.3.1 Hikma Pharmaceuticals plc Company Information
  15. 8.3.2 Hikma Pharmaceuticals plc Business Overview
  16. 8.3.3 Hikma Pharmaceuticals plc Gout Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hikma Pharmaceuticals plc Gout Medications Product Portfolio
  18. 8.3.5 Hikma Pharmaceuticals plc Recent Developments
  19. 8.4 lroko Pharmaceuticals
  20. 8.4.1 lroko Pharmaceuticals Company Information
  21. 8.4.2 lroko Pharmaceuticals Business Overview
  22. 8.4.3 lroko Pharmaceuticals Gout Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 lroko Pharmaceuticals Gout Medications Product Portfolio
  24. 8.4.5 lroko Pharmaceuticals Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Gout Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Gout Medications Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Novartis
  32. 8.6.1 Novartis Company Information
  33. 8.6.2 Novartis Business Overview
  34. 8.6.3 Novartis Gout Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novartis Gout Medications Product Portfolio
  36. 8.6.5 Novartis Recent Developments
  37. 8.7 Sanofi
  38. 8.7.1 Sanofi Company Information
  39. 8.7.2 Sanofi Business Overview
  40. 8.7.3 Sanofi Gout Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sanofi Gout Medications Product Portfolio
  42. 8.7.5 Sanofi Recent Developments
  43. 8.8 Savient Pharmaceuticals, Inc.
  44. 8.8.1 Savient Pharmaceuticals, Inc. Company Information
  45. 8.8.2 Savient Pharmaceuticals, Inc. Business Overview
  46. 8.8.3 Savient Pharmaceuticals, Inc. Gout Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Savient Pharmaceuticals, Inc. Gout Medications Product Portfolio
  48. 8.8.5 Savient Pharmaceuticals, Inc. Recent Developments
  49. 8.9 Sebelalreland
  50. 8.9.1 Sebelalreland Company Information
  51. 8.9.2 Sebelalreland Business Overview
  52. 8.9.3 Sebelalreland Gout Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sebelalreland Gout Medications Product Portfolio
  54. 8.9.5 Sebelalreland Recent Developments
  55. 8.10 Takeda Pharmaceutical Company Limited
  56. 8.10.1 Takeda Pharmaceutical Company Limited Company Information
  57. 8.10.2 Takeda Pharmaceutical Company Limited Business Overview
  58. 8.10.3 Takeda Pharmaceutical Company Limited Gout Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Takeda Pharmaceutical Company Limited Gout Medications Product Portfolio
  60. 8.10.5 Takeda Pharmaceutical Company Limited Recent Developments
  61. 8.11 Teijin Pharma
  62. 8.11.1 Teijin Pharma Company Information
  63. 8.11.2 Teijin Pharma Business Overview
  64. 8.11.3 Teijin Pharma Gout Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Teijin Pharma Gout Medications Product Portfolio
  66. 8.11.5 Teijin Pharma Recent Developments
  67. 8.12 Astellas Pharma Hong Kong Co., Ltd
  68. 8.12.1 Astellas Pharma Hong Kong Co., Ltd Company Information
  69. 8.12.2 Astellas Pharma Hong Kong Co., Ltd Business Overview
  70. 8.12.3 Astellas Pharma Hong Kong Co., Ltd Gout Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Astellas Pharma Hong Kong Co., Ltd Gout Medications Product Portfolio
  72. 8.12.5 Astellas Pharma Hong Kong Co., Ltd Recent Developments
  73. 8.13 Haichuang Pharmaceutical
  74. 8.13.1 Haichuang Pharmaceutical Company Information
  75. 8.13.2 Haichuang Pharmaceutical Business Overview
  76. 8.13.3 Haichuang Pharmaceutical Gout Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Haichuang Pharmaceutical Gout Medications Product Portfolio
  78. 8.13.5 Haichuang Pharmaceutical Recent Developments
  79. 8.14 Hengrui Medicine
  80. 8.14.1 Hengrui Medicine Company Information
  81. 8.14.2 Hengrui Medicine Business Overview
  82. 8.14.3 Hengrui Medicine Gout Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hengrui Medicine Gout Medications Product Portfolio
  84. 8.14.5 Hengrui Medicine Recent Developments
  85. 8.15 Tonghua Dongbao
  86. 8.15.1 Tonghua Dongbao Company Information
  87. 8.15.2 Tonghua Dongbao Business Overview
  88. 8.15.3 Tonghua Dongbao Gout Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Tonghua Dongbao Gout Medications Product Portfolio
  90. 8.15.5 Tonghua Dongbao Recent Developments
  91. 8.16 ApicHope
  92. 8.16.1 ApicHope Company Information
  93. 8.16.2 ApicHope Business Overview
  94. 8.16.3 ApicHope Gout Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 ApicHope Gout Medications Product Portfolio
  96. 8.16.5 ApicHope Recent Developments
  97. 8.17 INVENTISBIO CO. LTD.
  98. 8.17.1 INVENTISBIO CO. LTD. Company Information
  99. 8.17.2 INVENTISBIO CO. LTD. Business Overview
  100. 8.17.3 INVENTISBIO CO. LTD. Gout Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 INVENTISBIO CO. LTD. Gout Medications Product Portfolio
  102. 8.17.5 INVENTISBIO CO. LTD. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gout Medications Value Chain Analysis
  2. 9.1.1 Gout Medications Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gout Medications Production Mode & Process
  6. 9.2 Gout Medications Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gout Medications Distributors
  9. 9.2.3 Gout Medications Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst